Literature DB >> 8041735

Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis.

M C Pepin1, M Beauchemin, J Plamondon, M D O'Connor-McCourt.   

Abstract

Transforming growth factor beta (TGF-beta) receptor type III is a membrane-anchored proteoglycan that binds TGF-beta via the core protein. We have determined, by deletion mutagenesis of the receptor type III, the minimal essential region of the extracellular domain that is capable of binding TGF-beta. Nine deletion mutants were produced, six of which are expressed on the cell surface and bind TGF-beta. We find that the shortest of these active mutants, which retains only 253 of the 785 amino acids of the extracellular domain, binds TGF-beta with the same affinity as the full-length receptor. These results indicate that the ligand binding domain lies proximal to the transmembrane domain and is functionally independent from the rest of the extracellular domain. We have determined from the mutants that one of the potential glycosaminoglycan attachment sites in the receptor type III is not utilized. Results from the nonglycosylated mutants confirm that the glycosaminoglycan chains are not required for the folding, targeting, and TGF-beta binding activity of the receptor. Moreover, we present evidence for dimerization and multimerization of the receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041735      PMCID: PMC44325          DOI: 10.1073/pnas.91.15.6997

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases.

Authors:  H Y Lin; H F Lodish
Journal:  Trends Cell Biol       Date:  1993-01       Impact factor: 20.808

2.  Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II.

Authors:  M Laiho; F M Weis; F T Boyd; R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

3.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.

Authors:  F T Boyd; J Massagué
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

4.  The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors.

Authors:  S Cheifetz; J A Weatherbee; M L Tsang; J K Anderson; J E Mole; R Lucas; J Massagué
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

5.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

Authors:  R Ebner; R H Chen; L Shum; S Lawler; T F Zioncheck; A Lee; A R Lopez; R Derynck
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

6.  Interaction of transforming growth factor-beta 1 with alpha 2-macroglobulin. Role in transforming growth factor-beta 1 clearance.

Authors:  A Philip; M D O'Connor-McCourt
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

7.  Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.

Authors:  C Siepl; U V Malipiero; A Fontana
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

8.  Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein.

Authors:  E J Mitchell; K Lee; M D O'Connor-McCourt
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

9.  The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand.

Authors:  A Moustakas; H Y Lin; Y I Henis; J Plamondon; M D O'Connor-McCourt; H F Lodish
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

10.  Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans.

Authors:  D Fukushima; R Bützow; A Hildebrand; E Ruoslahti
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

View more
  12 in total

1.  Betaglycan has multiple binding sites for transforming growth factor-beta 1.

Authors:  S Kaname; E Ruoslahti
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.

Authors:  A Taniguchi; K Matsuzaki; K Nakano; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

3.  Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent.

Authors:  M M Vilchis-Landeros; J L Montiel; V Mendoza; G Mendoza-Hernández; F López-Casillas
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

Review 4.  Roles for the type III TGF-beta receptor in human cancer.

Authors:  Catherine E Gatza; Sun Young Oh; Gerard C Blobe
Journal:  Cell Signal       Date:  2010-02-12       Impact factor: 4.315

5.  Structure of betaglycan zona pellucida (ZP)-C domain provides insights into ZP-mediated protein polymerization and TGF-beta binding.

Authors:  S Jack Lin; Yaoxiong Hu; Jie Zhu; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

6.  Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.

Authors:  K Matsuzaki; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

7.  Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor.

Authors:  Valentín Mendoza; M Magdalena Vilchis-Landeros; Guillermo Mendoza-Hernández; Tao Huang; Maria M Villarreal; Andrew P Hinck; Fernando López-Casillas; Jose-Luis Montiel
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

8.  Expression, purification and characterization of BG(E)RII: a novel pan-TGFbeta inhibitor.

Authors:  Erik V Verona; Yuping Tang; Thomas K Millstead; Andrew P Hinck; Joseph K Agyin; Lu-Zhe Sun
Journal:  Protein Eng Des Sel       Date:  2008-05-21       Impact factor: 1.650

9.  Identification of a Novel TGF-β-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-β-Receptor-3 (TGFR-3).

Authors:  Uschi Diestel; Marcus Resch; Kathrin Meinhardt; Sigrid Weiler; Tina V Hellmann; Thomas D Mueller; Joachim Nickel; Jutta Eichler; Yves A Muller
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 10.  Dually modified transmembrane proteoglycans in development and disease.

Authors:  Laura M Jenkins; Ben Horst; Carly L Lancaster; Karthikeyan Mythreye
Journal:  Cytokine Growth Factor Rev       Date:  2017-12-22       Impact factor: 17.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.